Description

Methyl 4-Oxo-1-(4-(Trifluoromethyl)Phenyl)Cyclohexanecarboxylate CAS NO 1242314-02-8 is a high-purity, functionalized cyclohexanone derivative characterized by a trifluoromethylphenyl moiety. This compound is a critical pharmaceutical intermediate and building block for advanced organic synthesis, valued for its unique structural features that enable the development of novel active ingredients. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process chemistry.

Application

• Pharmaceutical Intermediate: A key synthon in the research and development of new therapeutic agents, particularly in central nervous system (CNS) and anti-inflammatory drug candidates.
• Agrochemical Synthesis: Serves as a precursor for novel pesticides and herbicides, leveraging the stability imparted by the trifluoromethyl group.
• Material Science Research: Used in the synthesis of specialty monomers and polymers with tailored thermal and chemical resistance properties.
• Organic Synthesis Building Block: Employed in academic and industrial R&D for constructing complex molecular architectures via reactions at the ketone and ester functional groups.
• Ligand and Catalyst Development: Acts as a scaffold for creating novel chiral ligands and organocatalysts used in asymmetric synthesis.

Basic Information

Product Name	Methyl 4-Oxo-1-(4-(Trifluoromethyl)Phenyl)Cyclohexanecarboxylate
CAS No.	1242314-02-8
Molecular Formula	C15H15F3O3
Molecular Weight	300.28 g/mol
Synonyms	Methyl 1-[4-(trifluoromethyl)phenyl]-4-oxocyclohexanecarboxylate; 4-Oxo-1-[4-(trifluoromethyl)phenyl]cyclohexanecarboxylic Acid Methyl Ester; 1-(4-Trifluoromethylphenyl)-4-oxocyclohexanecarboxylic Acid Methyl Ester; Cyclohexanecarboxylic acid, 4-oxo-1-[4-(trifluoromethyl)phenyl]-, methyl ester; Methyl 4-oxo-1-(p-trifluoromethylphenyl)cyclohexanecarboxylate
EINECS	Contact for details

Quality Control

Our Methyl 4-Oxo-1-(4-(Trifluoromethyl)Phenyl)Cyclohexanecarboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC and NMR, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specification parameters. Our quality commitment supports compliance with cGMP and ISO standards for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); ensure containers are sealed immediately after use to minimize exposure to atmospheric humidity. Keep away from incompatible materials such as strong bases and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.